EMD Millipore, the life science business of Merck KGaA of Darmstadt, Germany, has introduced enhancements to its Emprove portfolio of pharmaceutical raw materials. The expanded documentation and regulatory information facilitates drug product manufacturers’ risk assessment workflows and supplier qualification. The enhancements also help drug product manufacturers meet their own internal quality guidelines as well as those recently published by the European Commission. This was the first re...